BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines (Q36732681)
Jump to navigation
Jump to search
scientific article published on April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines |
scientific article published on April 2008 |
Statements
1 reference
BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines (English)
1 reference
Christine A Pratilas
1 reference
Rebecca Leboeuf
1 reference
Jacqueline E Baumgartner
1 reference
Miriam Benezra
1 reference
Roberta Malaguarnera
1 reference
David Solit
1 reference
Neal Rosen
1 reference
Jeffrey A Knauf
1 reference
James A Fagin
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference